Skip to Content

Luvox Side Effects

Generic Name: fluvoxamine

Note: This page contains information about the side effects of fluvoxamine. Some of the dosage forms included on this document may not apply to the brand name Luvox.

Not all side effects for Luvox may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to fluvoxamine: oral capsule extended release, oral tablet

In addition to its needed effects, some unwanted effects may be caused by fluvoxamine (the active ingredient contained in Luvox). In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking fluvoxamine:

Less common
  • Behavior, mood, or mental changes
  • trouble with breathing
  • trouble with urinating
  • twitching
  • Absence of or decrease in body movements
  • agitation
  • blurred vision
  • chills
  • clumsiness or unsteadiness
  • confusion
  • convulsions (seizures)
  • diarrhea
  • fever
  • inability to move the eyes
  • increase in body movements
  • menstrual changes
  • nosebleeds
  • overactive reflexes
  • poor coordination
  • red or irritated eyes
  • redness, tenderness, itching, burning, or peeling of the skin
  • restlessness
  • shivering
  • skin rash
  • sore throat
  • sweating
  • talking or acting with excitement you cannot control
  • trembling or shaking
  • unusual bruising
  • unusual, incomplete, or sudden body or facial movements
  • unusual secretion of milk (in females)
  • weakness

Some of the side effects that can occur with fluvoxamine may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common
  • Change in sexual performance or desire
  • constipation
  • headache
  • trouble sleeping
  • unusual tiredness
Less common
  • Abdominal or stomach pain
  • change in sense of taste
  • decreased appetite
  • feeling of constant movement of self or surroundings
  • frequent urination
  • heartburn
  • increased sweating
  • unusual weight gain or loss

For Healthcare Professionals

Applies to fluvoxamine: oral capsule extended release, oral tablet


Very common (10% or more): Nausea (40%), diarrhea (11%), constipation (10%), dyspepsia (10%)
Common (1% to 10%): Vomiting, flatulence, tooth disorder, dysphagia
Uncommon (0.1% to 1%): Gastrointestinal hemorrhage, melena
Rare (less than 0.1%): Ileus, pancreatitis[Ref]

Nervous system

Very common (10% or more): Headache (22%), somnolence (22%), nervousness (12%), dizziness (11%)
Common (1% to 10%): Tremor, hypertonia, agitation, CNS stimulation, taste perversion, hyperkinesia, myoclonus
Uncommon (0.1% to 1%): Abnormal dreams, akathisia, convulsion, dyskinesia, dystonia, euphoria, extrapyramidal syndrome, twitching
Frequency not reported: Paraesthesia[Ref]


Very common (10% or more): Insomnia (21%)
Common (1% to 10%): Anxiety, decreased libido, depression, manic depression
Rare (less than 0.1%): Withdrawal syndrome
Frequency not reported: Emotional lability, panic attacks, depersonalization, suicidal ideation[Ref]


Very common (10% or more): Asthenia (14%)
Common (10% or more): Flu syndrome, chills, malaise[Ref]


The most commonly reported side effects were nausea, diarrhea, headache, somnolence, asthenia, and insomnia.[Ref]


Common (1% to 10%): Palpitations, syncope
Frequency not reported: Tachycardia, bradycardia, postural hypotension
Postmarketing reports: Vasculitis, ventricular tachycardia (including torsades de pointes)[Ref]


Common (1% to 10%): Sweating
Uncommon (0.1% to 1%): Urticaria
Frequency not reported: Rash
Postmarketing reports: Bullous eruption, Henoch-Schonlein purpura, Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]


Common (1% to 10%): Abnormal ejaculation, urinary frequency, impotence, anorgasmia, urinary retention
Uncommon (0.1% to 1%): Hematuria, menorrhagia, vaginal hemorrhage
Rare (less than 0.1%): Hematospermia
Frequency not reported: Dysmenorrhea
Postmarketing reports: Amenorrhea[Ref]


Common (1% to 10%): Upper respiratory infection, dyspnea, yawn
Uncommon (0.1% to 1%): Epistaxis
Rare (less than 0.1%): Hemoptysis, laryngismus
Frequency not reported: Rhinitis, increased cough, epistaxis, sinusitis[Ref]


Frequency not reported: Hyperprolactinemia, galactorrhea[Ref]


Frequency not reported: Leg cramps, myalgia, arthralgia[Ref]


Uncommon (0.1% to 1%): Anemia, ecchymosis
Rare (less than 0.1%): Purpura
Frequency not reported: Ecchymosis
Postmarketing reports: Agranulocytosis, aplastic anemia[Ref]


Common (1% to 10%): Anorexia, weight gain, weight loss
Postmarketing reports: Porphyria
Frequency not reported: Thirst[Ref]


Common (1% to 10%): Amblyopia
Uncommon (0.1% to 1%): Photosensitivity
Frequency not reported: Visual disturbances (including abnormal or blurred vision), glaucoma[Ref]


Postmarketing reports: Renal failure[Ref]


Frequency not reported: Anaphylaxis
Postmarketing reports: Angioedema[Ref]


Postmarketing reports: Hepatitis[Ref]


1. "Product Information. Luvox (fluvoxamine)." Solvay Pharmaceuticals Inc, Marietta, GA.

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.